MedTrace Logo

Impact of Coronary Artery Stenting on Quantitative Myocardial Blood Flow and Health Status

NCT04475094 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 75

Last updated 2020-07-17

No results posted yet for this study

Summary

We propose to perform PET MPI studies in patients before and after stenting to evaluate changes (or lack thereof) in MBFR and how that is associated with changes (or lack thereof) in symptoms, functional status and quality of life. This will help to understand the role of MBFR in patient selection for coronary angiography and stenting.

Conditions

Interventions

DRUG

Rubidium-82

Consented subjects will undergo a rest/regadenoson stress myocardial perfusion PET study.

BEHAVIORAL

Seattle Angina Questionnaire-7

Consented subjects will complete a SAQ-7.

BEHAVIORAL

Rose Dyspnea Scale

Consented subjects will complete a RDS.

Sponsors & Collaborators

  • Cardiovascular Imaging Technologies

    lead INDUSTRY

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-12-23
Primary Completion
2021-12-31
Completion
2021-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04475094 on ClinicalTrials.gov